Demographics and Patient RCC Characteristics
| Characteristics | Patients N = 21 |
|---|---|
| Age, median years (range) | 56.0 (22-68) |
| Sex, n (%) | |
| Male | 16 (76) |
| Female | 5 (24) |
| Race, n (%) | |
| Caucasian | 19 (91) |
| Black | 1 (5) |
| Asian | 1 (5) |
| Time from diagnosis to 1stsunitinib dose, mean weeks (SD) | 10.8 (6.41) |
| ECOG performance status, n (%) | |
| 0 | 15 (71) |
| 1 | 6 (29) |
| MSKCC risk [23], n (%) | |
| Favorable (0 risk factors) | 0 |
| Intermediate (1-2 risk factors) | 15 (71) |
| Poor (≥3 risk factors) | 6 (29) |
| Heng risk [24], n (%) | |
| Favorable (0 risk factors) | 0 |
| Intermediate (1-2 risk factors) | 11 (52) |
| Poor (≥3 risk factors) | 10 (48) |
| Fuhrman nuclear grade, n (%) | |
| Grade 2 | 5 (24) |
| Grade 3 | 9 (43) |
| Grade 4 | 7 (33) |
| Tumor Size, n (%) | |
| TX | 2 (10) |
| T1 | 3 (14) |
| T2 | 1 (5) |
| T3 | 13 (62) |
| T4 | 2 (10) |
| Regional Lymph Nodes Staging, n (%) | |
| NX | 10 (48) |
| N0 | 6 (29) |
| N1 | 1 (5) |
| N2 | 4 (19) |
| Distant Metastasis Staging, n (%) | |
| M1 | 21 (100) |
ECOG = Eastern Cooperative Oncology Group MSKCC = Memorial Sloan Kettering Cancer Center; n = number of patients; SD = standard deviation.